SEDI Insider filing browser
Filter by Company
×
Filter by $CAD Amount
×
Filter by Filing Type
Filter by Insider
×
 
Date Issuer Insider Transaction Amount New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
Filed 2024-04-24 18:53
Tx date 2024-04-24 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$18,375
+3,750 vol
$4.90 each 		43,240
Filed 2024-04-24 18:52
Tx date 2024-04-24 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-18,375
-3,750 vol
$4.90 each 		203,250
Filed 2024-03-27 16:24
Tx date 2024-03-25 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$632,799
+70,000 vol
$9.04 each 		207,000
Filed 2023-08-20 13:03
Tx date 2023-08-18 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$10,010
+1,430 vol
$7.00 each 		7,680
Filed 2022-12-13 15:22
Tx date 2022-12-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$57,750
+15,000 vol
$3.85 each 		150,000
Filed 2022-10-27 13:25
Tx date 2022-06-29 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options
+35,000 vol 		137,000
Filed 2021-12-15 15:17
Tx date 2021-12-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$20,200
+10,000 vol
$2.02 each 		135,000
Filed 2021-03-10 17:27
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		6,250
Filed 2021-03-10 17:24
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report 		6,250
Filed 2021-03-10 17:24
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-10 17:12
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report 		3,125
Filed 2021-03-10 17:12
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Warrants
00 - Opening Balance-Initial SEDI Report 		3,125
Filed 2021-03-10 17:10
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Glickman, Spouse (Indirect Ownership)
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-10 17:10
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2021-03-10 17:08
Tx date 2021-03-09 		$EPRX
Eupraxia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		125,000
Filed 2021-01-05 15:29
Tx date 2020-09-25 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$8,832
+1,380 vol
$6.40 each 		8,460
Filed 2020-12-14 16:39
Tx date 2020-12-11 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$175,000
+25,000 vol
$7.00 each 		102,000
Filed 2020-09-24 15:55
Tx date 2020-09-24 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$9,585
+1,500 vol
$6.39 each 		7,080
Filed 2020-09-24 15:53
Tx date 2020-09-23 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$3,712
+580 vol
$6.40 each 		5,580
Filed 2020-09-24 15:41
Tx date 2020-09-23 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$36,736
+5,740 vol
$6.40 each 		39,490
Filed 2019-11-01 15:26
Tx date 2019-10-30 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$116,750
+25,000 vol
$4.67 each 		77,000
Filed 2019-10-16 13:04
Tx date 2019-10-07 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$96,900
+30,000 vol
$3.23 each 		52,000
Filed 2019-06-27 18:48
Tx date 2019-06-25 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$60,000
+20,000 vol
$3.00 each 		75,000
Filed 2019-02-12
Tx date 2019-02-08 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$50,599
+10,000 vol
$5.06 each 		22,000
Filed 2019-01-29
Tx date 2019-01-29 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$29,970
+3,700 vol
$8.10 each 		1,021,206
Filed 2019-01-29
Tx date 2019-01-29 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$25,110
+3,100 vol
$8.10 each 		113,789
Filed 2019-01-29
Tx date 2019-01-29 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Common Shares
10 - Acquisition or disposition in the public market 		$9,720
+1,200 vol
$8.10 each 		110,689
Filed 2018-12-14
Tx date 2018-12-10 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Common Shares
54 - Exercise of warrants 		$7,499
+3,500 vol
$2.14 each 		109,489
Filed 2018-12-14
Tx date 2018-12-10 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Warrants
54 - Exercise of warrants 		$-7,499.80
-3,500 vol
$2.14 each 		0
Filed 2018-12-14
Tx date 2013-09-20 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Indirect Ownership)
Warrants
00 - Opening Balance-Initial SEDI Report 		3,500
Filed 2018-11-23
Tx date 2018-11-20 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-76,500
-15,000 vol
$5.10 each 		55,000
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report 		14,444
Filed 2018-06-20
Tx date 2018-05-25 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
00 - Opening Balance-Initial SEDI Report 		50,000
Filed 2018-06-20
Tx date 2018-06-19 		$CORV
Correvio Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$97,000
+20,000 vol
$4.85 each 		70,000
Filed 2018-05-30
Tx date 2018-05-25 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$205,403
+74,153 vol
$2.77 each 		1,017,506
Filed 2018-05-30
Tx date 2018-05-25 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Michelle Lynn Glickman (Control or Direction)
Common Shares
54 - Exercise of warrants 		$222,222
+88,889 vol
$2.50 each 		105,989
Filed 2018-05-30
Tx date 2018-05-23 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
54 - Exercise of warrants 		$205,403
+74,153 vol
$2.77 each
Filed 2018-05-30
Tx date 2018-05-25 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-222,222.50
-88,889 vol
$2.50 each 		74,152
Filed 2018-05-30
Tx date 2018-05-25 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Warrants
54 - Exercise of warrants 		$-205,401.04
-74,152 vol
$2.77 each 		0
Filed 2018-04-26
Tx date 2018-04-25 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
37 - Stock split or consolidation
-228,000 vol 		12,000
Filed 2018-04-26
Tx date 2018-04-25 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Holder: Spouse (Indirect Ownership)
Common Shares
37 - Stock split or consolidation
-95,000 vol 		5,000
Filed 2018-04-26
Tx date 2018-04-25 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
37 - Stock split or consolidation
-641,250 vol 		33,750
Filed 2018-03-06
Tx date 2018-02-21 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$40,425
+165,000 vol
$0.245 each 		240,000
Filed 2018-03-06
Tx date 2018-02-21 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$18,375
+75,000 vol
$0.245 each 		75,000
Filed 2018-03-06
Tx date 2018-02-21 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-60,000
-75,000 vol
$0.80 each 		0
Filed 2018-02-06
Tx date 2018-02-05 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$2,568,000
+400,000 vol
$6.42 each 		1,670,000
Filed 2017-11-17
Tx date 2017-11-17 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
10 - Acquisition or disposition in the public market 		$25,857
+3,900 vol
$6.63 each 		943,353
Filed 2017-08-18
Tx date 2017-08-15 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
51 - Exercise of options 		$-37,400
-22,000 vol
$1.70 each 		53,000
Filed 2017-08-18
Tx date 2017-08-14 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$63,125
+12,500 vol
$5.05 each 		75,000
Filed 2017-08-18
Tx date 2017-08-15 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
51 - Exercise of options 		$24,554
+14,444 vol
$1.70 each 		14,444
Filed 2017-08-18
Tx date 2006-12-11 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
00 - Opening Balance-Initial SEDI Report
Filed 2017-02-13
Tx date 2017-02-09 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$4,420,500
+1,050,000 vol
$4.21 each 		1,270,000
Filed 2016-08-15
Tx date 2016-08-11 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$50,125
+12,500 vol
$4.01 each 		62,500
Filed 2016-06-28
Tx date 2016-06-22 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Warrants
11 - Acquisition or disposition carried out privately 		$205,401
+74,152 vol
$2.77 each 		163,041
Filed 2016-06-27
Tx date 2016-06-22 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
11 - Acquisition or disposition carried out privately 		$500,001
+211,865 vol
$2.36 each 		939,453
Filed 2016-03-25
Tx date 2016-03-23 		$AUPH
Aurinia Pharmaceuticals Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$39,600
+10,000 vol
$3.96 each 		220,000
Filed 2015-10-16
Tx date 2015-10-09 		$EPI
ESSA Pharma Inc. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Common Shares
90 - Change in the nature of ownership
-70,000 vol 		675,000
Filed 2015-06-26
Tx date 2015-06-22 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
50 - Grant of options 		$116,600
+10,000 vol
$11.66 each 		50,000
Filed 2015-05-28
Tx date 2015-05-25 		$COM
Cardiome Pharma Corp. 		Glickman, Richard
4 - Director of Issuer
Direct Ownership
Options
52 - Expiration of options 		$-124,200
-3,000 vol
$41.40 each 		40,000